| Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging MK Chen, AP Mecca, M Naganawa, SJ Finnema, T Toyonaga, S Lin, ... JAMA neurology 75 (10), 1215-1224, 2018 | 367 | 2018 |
| Lower synaptic density is associated with depression severity and network alterations SE Holmes, D Scheinost, SJ Finnema, M Naganawa, MT Davis, ... Nature communications 10 (1), 1529, 2019 | 350 | 2019 |
| PET kinetic analysis—compartmental model H Watabe, Y Ikoma, Y Kimura, M Naganawa, M Shidahara Annals of nuclear medicine 20, 583-588, 2006 | 251 | 2006 |
| In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET AP Mecca, MK Chen, RS O'Dell, M Naganawa, T Toyonaga, TA Godek, ... Alzheimer's & Dementia 16 (7), 974-982, 2020 | 195 | 2020 |
| High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C] SA4503 M Ishikawa, K Ishiwata, K Ishii, Y Kimura, M Sakata, M Naganawa, K Oda, ... Biological psychiatry 62 (8), 878-883, 2007 | 174 | 2007 |
| Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis M Naganawa, Y Kimura, K Ishii, K Oda, K Ishiwata, A Matani IEEE transactions on biomedical engineering 52 (2), 201-210, 2005 | 142 | 2005 |
| Synaptic changes in Parkinson disease assessed with in vivo imaging D Matuskey, S Tinaz, KC Wilcox, M Naganawa, T Toyonaga, M Dias, ... Annals of neurology 87 (3), 329-338, 2020 | 137 | 2020 |
| Adenosine A2A Receptors Measured with [11C]TMSX PET in the Striata of Parkinson's Disease Patients M Mishina, K Ishiwata, M Naganawa, Y Kimura, S Kitamura, M Suzuki, ... PLoS One 6 (2), e17338, 2011 | 137 | 2011 |
| Assessment of a white matter reference region for 11C-UCB-J PET quantification S Rossano, T Toyonaga, SJ Finnema, M Naganawa, Y Lu, N Nabulsi, ... Journal of Cerebral Blood Flow & Metabolism 40 (9), 1890-1901, 2020 | 96 | 2020 |
| Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD YS Ding, M Naganawa, JD Gallezot, N Nabulsi, SF Lin, J Ropchan, ... Neuroimage 86, 164-171, 2014 | 96 | 2014 |
| Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET M Mishina, K Ishiwata, Y Kimura, M Naganawa, K Oda, S Kobayashi, ... Synapse 61 (9), 778-784, 2007 | 91 | 2007 |
| Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB‐J AP Mecca, RS O'Dell, ES Sharp, ER Banks, HH Bartlett, W Zhao, S Lipior, ... Alzheimer's & Dementia 18 (12), 2527-2536, 2022 | 85 | 2022 |
| Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology RH Pietrzak, M Naganawa, Y Huang, S Corsi-Travali, MQ Zheng, ... JAMA psychiatry 71 (11), 1262-1270, 2014 | 79 | 2014 |
| Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J RS O’Dell, AP Mecca, MK Chen, M Naganawa, T Toyonaga, Y Lu, ... Alzheimer's Research & Therapy 13, 1-12, 2021 | 71 | 2021 |
| First-in-human evaluation of 18F-SynVesT-1, a radioligand for PET imaging of synaptic vesicle glycoprotein 2A M Naganawa, S Li, N Nabulsi, S Henry, MQ Zheng, R Pracitto, Z Cai, ... Journal of Nuclear Medicine 62 (4), 561-567, 2021 | 71 | 2021 |
| Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study MK Chen, AP Mecca, M Naganawa, JD Gallezot, T Toyonaga, J Mondal, ... Journal of Cerebral Blood Flow & Metabolism 41 (9), 2395-2409, 2021 | 66 | 2021 |
| In vivo synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib in a mouse model of Alzheimer disease T Toyonaga, LM Smith, SJ Finnema, JD Gallezot, M Naganawa, J Bini, ... Journal of Nuclear Medicine 60 (12), 1780-1786, 2019 | 66 | 2019 |
| Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C] SA4503 M Sakata, Y Kimura, M Naganawa, K Oda, K Ishii, K Chihara, K Ishiwata Neuroimage 35 (1), 1-8, 2007 | 65 | 2007 |
| In vivo evidence of lower synaptic vesicle density in schizophrenia R Radhakrishnan, PD Skosnik, M Ranganathan, M Naganawa, ... Molecular Psychiatry 26 (12), 7690-7698, 2021 | 64 | 2021 |
| Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11C]UCB‐J positron emission tomography study SJ Finnema, T Toyonaga, K Detyniecki, MK Chen, M Dias, Q Wang, ... Epilepsia 61 (10), 2183-2193, 2020 | 62 | 2020 |
Richard E. CarsonProfessor of Radiology and Biomedical Imaging and of Biomedical Engineering在 yale.edu 的电子邮件经过验证
